skip to main content

The pill that might be relieving your heartburn but killing your gut microbes

Nature

19.06.2025 In the Media

Why drugs commonly used against heartburn harm your gut microbiome

Proton pump inhibitors (PPIs) such as omeprazole are frequently used to treat heartburn – often without medical necessity. However, regular use can disrupt the delicate balance of the gut microbiome, thereby increasing the risk of Clostridioides difficile infections and chronic diseases such as obesity and diabetes.

A recent study led by CMFI Board Member Lisa Maier shows that it is not the active ingredient itself, but the sustained increase in pH in the intestine that affects key microbes. In bioreactor experiments, the researchers demonstrated that a permanently elevated pH value alters the composition of the microbiome and weakens its protective function against pathogens such as C. difficile – whereas omeprazole alone had no direct effect.

The results make it clear that a shift in the intestinal environment caused by PPIs can have far-reaching consequences. People who regularly suffer from heartburn should therefore also consider lifestyle changes – to protect the microbiome and maintain their own health in the long term.

Libera Lo Presti from CMFI wrote a “Behind the Paper” post for the Research Communities blog by Springer Nature.

Springer Nature - Behind the Paper


Publication:

Schumacher J, Müller P, Sulzer J, Faber F, Molitor B, Maier L. (2025) Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model. Gut Microbes. 17(1):2519697. doi: 10.1080/19490976.2025.2519697.

Scientific Contact

Lisa Maier

Universität Tübingen

Interfaculty Institute for Microbiology and Infection Medicine

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

l.maier@uni-tuebingen.de

Website

 

Press Contact

Leon Kokkoliadis
Public Relations Management

University of Tübingen

Interfaculty Institute for Microbiology and Infection Medicine (IMIT)

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

Tel: +49 7071 29-74707 / +49 152 346 79 269

E-Mail: leon.kokkoliadis@uni-tuebingen.de

More News

VAAM Award for Best Poster goes to Justine Camus
13.04.2026 VAAM Award for Best Poster goes to Justine Camus CMFI News
CMFI exhibition MicroPop gains international attention
09.04.2026 CMFI exhibition MicroPop gains international attention CMFI News
Listeria-infected macrophages weaken blood vessel barriers to spread infection
23.03.2026 Listeria-infected macrophages weaken blood vessel barriers to spread infection CMFI News
Küstenchemie der Weltmeere: Menschen hinterlassen überall chemische Spuren
17.03.2026 Küstenchemie der Weltmeere: Menschen hinterlassen überall chemische Spuren Press Release
"Paper in a Minute" – Resistance Training Reshapes the Gut Microbiome in a Longitudinal 8-Week Intervention in Sedentary Adults
16.03.2026 "Paper in a Minute" – Resistance Training Reshapes the Gut Microbiome in a Longitudinal 8-Week Intervention in Sedentary Adults CMFI News
Tübingen once more selected as a University of Excellence
11.03.2026 Tübingen once more selected as a University of Excellence Press Release